Corporate Board Profile
Tech Score: 10/100
1 mention(s) identify MARK J. AHN, PH.D. as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
ABEONA THERAPEUTICS INC. | 2012-04-16 | Dr. Ahn’s qualifications to serve on our Board include his strong executive leadership, management, financial and operational skills in successfully leading Hana Biosciences. | He has a Ph.D. in Business Administration and has held various positions in biotechnology and pharmaceuticals, indicating a strong technical background, though no direct programming experience is mentioned. |
Filing Date | Source Excerpt |
---|---|
2007-04-13 | Dr. Ahn received a B.A. in History and an M.B.A. in Finance from Chaminade University. He was a graduate fellow in Economics at Essex University, and has a Ph.D. in Business Administration from the University of South Australia. |
2008-04-22 | Dr. Ahn received a B.A. in History and an M.B.A. in Finance from Chaminade University. |
2009-04-22 | Dr. Ahn received a B.A. in History and an M.B.A. in Finance from Chaminade University. |
2010-04-16 | Dr. Mark J. Ahn became a director in September 2006 and is chairman of the Compensation Committee. Dr. Ahn is also a member of the Audit and Finance Committee and the Nominating & Corporate Governance Committee. |
2011-04-14 | Dr. Ahn’s qualifications to serve on our Board include his strong executive leadership, management, financial and operational skills. |
2012-04-16 | Dr. Ahn’s qualifications to serve on our Board include his strong executive leadership, management, financial and operational skills in successfully leading Hana Biosciences. |
2013-04-02 | Mark J. Ahn, Ph.D. became a director in September 2006 and is chairman of the Compensation Committee. |
2014-04-15 | Dr. Ahn currently serves as President and Chief Executive Officer since 2011 and as a director since 2007 of Galena Biopharma, Inc.; and adjunct Professor, Biosciences at Creighton University. |
2015-04-07 | Dr. Ahn brings more than 22 years of experience in the biopharmaceutical industry. |
2016-04-06 | Dr. Ahn is a Principal at Pukana Partners LLC which provides strategic consulting to life science companies. |
Data sourced from SEC filings. Last updated: 2025-07-01